Risk factors of mortality in perforated peptic ulcer

European Journal of Surgery

Volumn 166, Issue 2, 2000, Pages 149-153

  Chou, Nan Hua ^a,b   Mok, King Tong ^a   Chang, Hong Tai ^a   Liu, Shiuh Inn ^a   Tsai, Cheng Chung ^a   Wang, Being Whey ^a   Chen, I Shu ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Albumin; Anti HP treatment; Concurrent medical illness; Definitive operation; Delay treatment; Helicobacter pylori (HP); Nutrition; Simple closure

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HELICOBACTER PYLORI; HUMAN; HYPOVOLEMIC SHOCK; MAJOR CLINICAL STUDY; NUTRITIONAL SUPPORT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TAIWAN; TREATMENT OUTCOME; ULCER PERFORATION;

EID: 0033969169     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241500750009500     Document Type: Article

References (19)

1. Blomgren LG. Perforated peptic ulcer: long-term results after simple closure in the elderly. World J Surg 1997: 21: 412-414.
2. Bodner B. Harrington ME, Kim U. A multifactorial analysis of mortality and morbidity in perforated peptic ulcer disease. Surg Gynecol Obstet 1990; 171: 315-320.
3. Boey J, Wong J. A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg 1982; 195: 265-269.
4. Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin North Am 1992; 72: 445-465.
5. Fineberg HV, Pearlman LA. Surgical treatment of peptic ulcer in the United States: Trends before and after the introduction of cimetidine. Lancet 1981; i: 1305-1307.
6. Freston JW. Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 121-140.
7. Gibaldi M. Helicobacter pylori and gastrointestinal disease. J Clin Pharmacol 1995; 35: 647-654.
8. Hamby LS, Zweng TN, Strodel WE. Perforated gastric and duodenal ulcer: an analysis of prognostic factors. Am Surg 1993; 59: 319-324.
9. Makela J, Laitinen S, Kairaiuoma MI. Complications of peptic ulcer disease before and after the introduction of H2-receptor antagonists. Hepatogastroenterology 1992; 39: 144-148.
10. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-1314.
11. Mattingly SS. Griffen WO. Factors influencing morbidity and mortality in perforated duodenal ulcer. Am Surg 1980; 46: 61-66.
12. Negre J. Perforated peptic ulcer in elderly patients. Lancet 1985; ii: 1118-1119.
13. Scheeres DE, Dekryger LL, Dean RE. Surgical treatment of peptic ulcer disease before and after introduction of H2-blockers. Am Surg 1987; 7: 392-395.
14. Schwarz K. Uber penetricrende magen und jejunalgeschwür. Beitr Klin Chir 1910; 67: 96.
15. Sebastian M, Chandran VPP, Elashaal YIM, et al. Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg 1995; 82: 360-362.
16. Svanes C, Salvesen H, Stangeland L, et al. Perforated peptic ulcer over 56 years. Time trends in patients and disease characteristics. Gut 1993; 34: 1666-1671.
17. Tokunaga Y, Hata K, Ryo J, et al. Density of Helicobacter pylori infection in patients with peptic ulcer perforation. J Am Coll Surg 1998; 186: 659-663.
18. Tovey FI, Godfrey JE, Lewin MR. A gastrectomy population: 25-30 years on. Postgrad Med J 1990; 66: 450-456.
19. Watkins RM, Dennison AR, Collin J. What has happened to perforated peptic ulcer? Br J Surg 1984: 71: 774-776.